How Migraine Medications Are Tested
Posted on December 10 2024,

1. Testing Immediate Relief Medications (Acute Treatment)
What's Being Tested | Previous Standards | Current Standards |
---|---|---|
How Often Patients Need to Have Migraine Attacks to Join the Study | 1-6 migraine attacks per month | 2-8 migraine attacks per month, <15 headache days |
How Success is Measured (primary endpoint) |
Whether migraine attack resolved at 2 hours |
Whether pain is completely gone at 2 hours AND most bothersome symptom |
Additional Success Measures | Just pain relief | • Complete pain relief • Relief from most bothersome symptom • Whether relief lasts for 24-48 hours |
Side Effect Tracking | Basic tracking | Detailed reporting of all side effects |
2. Testing Preventive Medications
What's Being Tested | Previous Standards | Current Standards |
---|---|---|
Who Can Participate | People with 2-6 migraine attacks monthly | People with up to 15 migraine attacks monthly |
How Success is Measured (primary endpoint) | Counting fewer attacks | Either: • Fewer migraine attack days per month • At least 50% reduction in migraine days (should be the secondary endpoint, if not the primary) |
3. Special Cases
For People with Chronic Migraine
What's Important | Details |
---|---|
Who Can Participate | People can be included even if they have medication overuse/adaptation headache |
Success Measures (primary endpoint) | Reduction in number of moderate/severe headache days |
Additional Benefits (secondary endpoint) | Whether migraine attacks become less frequent overall (conversion to episodic migraine) |
For Children and Adolescents
What's Important | Details |
---|---|
Age Groups | Ages 6-17 allowed to participate |
Special Requirements | • Must have had migraine attacks for at least 6 months • Parents can help report symptoms • Studies must run year-round (not just during school) |
For Migraine with Visual/Sensory/Speech or Language Symptoms (Aura)
What's Important | Details |
---|---|
Minimum Requirement | At least one migraine with aura monthly |
Success Measures | • How often auras occur (primary endpoint) • How often headaches follow the aura (secondary endpoint) |
Thu, Aug 07, 25
Dizziness and Migraine: When is it Vestibular Migraine?
Dizziness and migraine: Learn when dizziness is vestibular migraine vs BPPV, Meniere's disease, or vascular causes. Guide covers symptoms, diagnosis, cutaneous allodynia, and treatment options for recurrent dizziness episodes.
Read MoreMon, Aug 04, 25
Evidence-Based Guide to Migraine Nutraceuticals and Herbal Options
Evidence-based guide to natural migraine treatments including riboflavin, magnesium, ginger, and CoQ10. Compare effectiveness, dosing, and safety of 15+ nutraceuticals and herbal remedies for migraine prevention and acute treatment with...
Read MoreMon, Jul 28, 25
Status Migrainosus Guide: A migraine attack lasting 72 hours or more
Status migrainosus is a severe migraine complication lasting over 72 hours requiring emergency treatment. Learn evidence-based management strategies, IV therapy protocols, diagnostic criteria, and prognosis from this comprehensive clinical guide...
Read More